Putnam BDC Income ETF Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Sell

35

PBDC
Putnam BDC Income ETF

Last Price:

$30.87

Seasonality Move:

4.29%

Sell

34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:

$54.85

Seasonality Move:

-11.9%

Sell

35

Putnam BDC Income ETF (PBDC) is a Sell

Is Putnam BDC Income ETF a Buy, Sell or Hold?

The current Putnam BDC Income ETF [PBDC] share price is $30.88. The Score for PBDC is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
PBDC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

34

Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PBDC Stock Price Chart

What is Putnam BDC Income ETF's stock price today?

The Putnam BDC Income ETF share price today is $30.88

The current trend is relatively stagnant and PBDC is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

The Crinetics Pharmaceuticals, Inc. share price today is $53.24

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

PBDC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.1	Sell
Relative Strength Index (14 RSI):	51.07	Buy
Chaikin Money Flow:	78886	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(30.36 - 31.76)	Sell
Bollinger Bands (100):	(30.09 - 32.79)	Sell

CRNX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.28	Buy
Relative Strength Index (14 RSI):	65.68	Buy
Chaikin Money Flow:	-209678	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(46.25 - 50.15)	Buy
Bollinger Bands (100):	(35.32 - 47.44)	Buy

PBDC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	30.65	Buy
20-day SMA:	30.86	Buy
50-day SMA:	30.78	Buy
200-day SMA:	32.25	Sell
8-day EMA:	30.66	Buy
20-day EMA:	30.76	Buy
50-day EMA:	30.93	Sell
200-day EMA:	32.09	Sell

CRNX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	48.77	Buy
20-day SMA:	48.57	Buy
50-day SMA:	45.67	Buy
200-day SMA:	36.1	Buy
8-day EMA:	49.69	Buy
20-day EMA:	48.35	Buy
50-day EMA:	45.87	Buy
200-day EMA:	40.28	Buy

Putnam BDC Income ETF Earnings Growth & PBDC Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

Putnam BDC Income ETF Technical Analysis

	Dec 24	Dec 26	Dec 29	Dec 30	Dec 31	Jan 2	Jan 5	Jan 6	Jan 7	Jan 8
	Dec						Jan
	24	26	29	30	31	02	05	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

	Dec 23	Dec 24	Dec 26	Dec 29	Dec 30	Dec 31	Jan 5	Jan 6	Jan 7	Jan 8
	Dec							Jan
	23	24	26	29	30	31	05	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):